
Czech Tech Horizons invests in Sensible Biotechnologies. $47 million funding round to support mRNA therapeutics and strengthen Europe’s resilience to biological threats
Tech Horizons, a VC fund investing in technologies that strengthen Western sovereignty, has invested in biotechnology startup Sensible Biotechnologies. The company is developing the first fully integrated cell-based platform of its kind for the design, optimisation and manufacturing of mRNA using living cells.
